BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6738408)

  • 21. Drug therapy reviews: pathogenesis and clinical management of hyperuricemia and gout.
    Mangini RJ
    Am J Hosp Pharm; 1979 Apr; 36(4):497-504. PubMed ID: 433935
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapeutic criteria in hyperuricemia].
    Sancho Bueso T; Garcia Puig J
    Rev Clin Esp; 2001 Feb; 201(2):85-7. PubMed ID: 11345611
    [No Abstract]   [Full Text] [Related]  

  • 23. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.
    Halpern R; Mody RR; Fuldeore MJ; Patel PA; Mikuls TR
    Curr Med Res Opin; 2009 Jul; 25(7):1711-9. PubMed ID: 19485724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urate-lowering therapy for the management of gout: a summary of 2 Cochrane reviews.
    Kydd AS; Seth R; Buchbinder R; Falzon L; Edwards CJ; van der Heijde DM; Bombardier C
    J Rheumatol Suppl; 2014 Sep; 92():33-41. PubMed ID: 25180126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patients with gout can be cured in primary care.
    Rees F; Doherty M
    Practitioner; 2014 Dec; 258(1777):15-9, 2. PubMed ID: 25603588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis and clinical management of hyperuricemia and gout.
    Mangini RJ
    J Maine Med Assoc; 1979 Mar; 70(3):118-20, 122-7. PubMed ID: 374661
    [No Abstract]   [Full Text] [Related]  

  • 27. Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and gout.
    Feher MD; Hepburn AL; Hogarth MB; Ball SG; Kaye SA
    Rheumatology (Oxford); 2003 Feb; 42(2):321-5. PubMed ID: 12595630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of acute and chronic gouty arthritis: present state-of-the-art.
    Schlesinger N
    Drugs; 2004; 64(21):2399-416. PubMed ID: 15481999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pathogenesis and therapy of gout].
    Mertz DP
    Med Klin; 1971 Apr; 66(17):623-6. PubMed ID: 4994876
    [No Abstract]   [Full Text] [Related]  

  • 30. [Gout (pathogenesis and therapy)].
    Chirone E
    Policlinico Prat; 1968 Feb; 75(6):177-87. PubMed ID: 5744779
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative trial of azapropazone and indomethacin plus allopurinol in acute gout and hyperuricaemia.
    Fraser RC; Davis RH; Walker FS
    J R Coll Gen Pract; 1987 Sep; 37(302):409-11. PubMed ID: 3330140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of gout and hyperuricemia.
    Wisner DE; Simkin PA
    Prim Care; 1984 Jun; 11(2):283-94. PubMed ID: 6206519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Editorial: Therapy of gout nowadays (author's transl)].
    Mertz DP
    Schweiz Rundsch Med Prax; 1974 Oct; 63(40):1185-7. PubMed ID: 4445089
    [No Abstract]   [Full Text] [Related]  

  • 34. [Summary of the Dutch College of General Practitioners' "Gout" Standard].
    Romeijnders AC; Gorter KJ
    Ned Tijdschr Geneeskd; 2002 Feb; 146(7):309-13. PubMed ID: 11876034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rational pharmacotherapy (RPT) in goutology: Define the serum uric acid target & treat-to-target patient cohort and review on urate lowering therapy (ULT) applying synthetic drugs.
    Jansen TL
    Joint Bone Spine; 2015 Jul; 82(4):225-9. PubMed ID: 26113027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelets and vascular disease in gout.
    Bluhm GB; Riddle JM
    Semin Arthritis Rheum; 1973; 2(4):355-66. PubMed ID: 4702575
    [No Abstract]   [Full Text] [Related]  

  • 37. Improving cardiovascular and renal outcomes in gout: what should we target?
    Richette P; Perez-Ruiz F; Doherty M; Jansen TL; Nuki G; Pascual E; Punzi L; So AK; Bardin T
    Nat Rev Rheumatol; 2014 Nov; 10(11):654-61. PubMed ID: 25136785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic advances in gout.
    Pascual E; Sivera F
    Curr Opin Rheumatol; 2007 Mar; 19(2):122-7. PubMed ID: 17278926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on emerging urate-lowering therapies.
    Chohan S; Becker MA
    Curr Opin Rheumatol; 2009 Mar; 21(2):143-9. PubMed ID: 19339925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperuricemia and gout. Classification, complications and management.
    Boss GR; Seegmiller JE
    N Engl J Med; 1979 Jun; 300(26):1459-68. PubMed ID: 221806
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.